Skip Navigation Links.
Activity Information
Introduction
Expert Perspective
References
Finish

Online CME Activity

Celiac Disease and Gluten Sensitivity Update: Insights Into Testing and Treatment


NOTE: Although this activity is no longer certified for credit, we believe that it contains important information and hope you’ll review, print or email it to a colleague.

Title:
Celiac Disease and Gluten Sensitivity Update: Insights Into Testing and Treatment
Release Date:
01/12/2011
Expiration Date:
01/12/2012
Topics:
Gastroenterology
Primary Audience:
Primary Care
Activity Format:
Expert Perspective
Credits:
1.00 AMA PRA Category 1 Credits™, 1.00 AANP, 1.00 ANCC

 
Overall Satisfaction Rating:
Full Star Full Star Full Star Full Star Empty Star 83%

Learning Objectives

Understand the implications of serological, biopsy, and genetic test results to appropriately manage patients with gastrointestinal symptoms suggestive of celiac disease.

Accreditation

This educational program is conceived and credited in accordance with ACCME's Essential Areas and Policies, including the 2004 Updated Standards for Commercial Support. Pri-Med faculty hail from a variety of institutions and participate in content development, along with pmiCME's Advisory Boards and its expert review partners, the University of Wisconsin School of Medicine and Public Health and Tufts Health Care Institute. All final decisions about program content are the responsibility of pmiCME.

Credits Type Accreditation Statement Designation Statement
1.00 AMA PRA Category 1 Credits™ pmiCME is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. pmiCME designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
1.00 AANP pmiCME is approved as a provider of nurse practitioner continuing education programs by the American Academy of Nurse Practitioners. AANP Provider number 040308. This program has been approved for 1 contact hours of continuing education, which includes .5 hour of pharmacology.
1.00 ANCC pmiCME is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. This activity for 1 contact hours is provided by pmiCME.

Faculty and Editorial Board

Written By: Christine L. Frissora, MD, (Read Bio), Associate Professor of Medicine, Weill Medical College of Cornell University, New York, NY, Assistant Attending Physician, New York-Presbyterian Hospital Cornell Campus

Edited By: Carolyn Skowronski, PharmD, pmiCME

Financial Disclosure Statement(s)

Dr Frissora receives speakers bureau honoraria from Prometheus and Salix, and research support from Tioga.

Ms Skowronski holds stock in Merck.

Education Partner:

n/a

Commercial Support:

n/a

Instructions for Obtaining Credit:

Complete this activity. Answer the questions in the attached posttest and evaluation. Click on "claim credit" and follow the instructions to print out the credit certificate.

Computer System Requirements:

Internet Explorer (version 5.5 and above) is the recommended browser for Pri-Med Online eCME activities. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A minimum screen resolution setting of 800 x 600 is recommended. A high-speed Internet connection (DSL, cable modem, or LAN-based) is not required; however, it is recommended for faster download times.

Disclaimer

The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed, nor do they necessarily reflect, those of their affiliated institutions, pmiCME, pmiCME Advisory Boards and Consultants, or M|C Communications, LLC.

Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.